Objectives The objective of the study was to outline key considerations for general clinical readers when critically evaluating publications on platform trials and for researchers when …
Adaptive designs (ADs) allow pre-planned changes to an ongoing trial without compromising the validity of conclusions and it is essential to distinguish pre-planned from …
Y Wang, F Zhou, D Zhang, J Zhao, R Du, Y Hu… - Trials, 2020 - Springer
Abstract Background Coronavirus disease 2019 (COVID-19), caused by a novel corinavirus (later named SARS-CoV-2 virus), was fistly reported in Wuhan, Hubei Province, China …
Adaptive designs for clinical trials permit alterations to a study in response to accumulating data in order to make trials more flexible, ethical, and efficient. These benefits are achieved …
N Stallard, L Hampson, N Benda… - Statistics in …, 2020 - Taylor & Francis
The COVID-19 pandemic has led to an unprecedented response in terms of clinical research activity. An important part of this research has been focused on randomized …
SP Patil, ME Billings, G Bourjeily, NA Collop… - Journal of Clinical …, 2024 - jcsm.aasm.org
This multisociety commentary critically examines the Agency for Healthcare Research and Quality (AHRQ) final report and systematic review on long-term health outcomes in …
R Tunn, I Boutron, AW Chan, GS Collins… - Journal of Clinical …, 2024 - Elsevier
Objectives To describe, and explain the rationale for, the methods used and decisions made during development of the updated SPIRIT 2024 and CONSORT 2024 reporting guidelines …
Introduction Randomised controlled trials (RCTs) may use surrogate endpoints as substitutes and predictors of patient-relevant/participant-relevant final outcomes (eg …
Abstract Background and Objective The minimum sample size for multistakeholder Delphi surveys remains understudied. Drawing from three large international multistakeholder …